Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro

Toxicological Sciences

Volumn 120, Issue 1, 2011, Pages 42-58

  Benninghoff, Abby D ^a   Bisson, William H ^b   Koch, Daniel C ^c   Ehresman, David J ^d   Kolluri, Siva K ^c   Williams, David E ^c  

^a UTAH STATE UNIVERSITY   (United States)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c OREGON STATE UNIVERSITY   (United States)

^d 3M COMPANY   (United States)

Author keywords

Estrogen; Molecular docking; Perfluoroalkyl acid; Perfluorooctane sulfonate; Perfluorooctanoic acid; Vitellogenin

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CARBOXYLIC ACID; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; NONYLPHENOL; PERFLUORO COMPOUND; PERFLUORODECANOIC ACID; PERFLUORONONANOIC ACID; PERFLUOROOCTANOIC ACID; VITELLOGENIN;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL STRUCTURE; COMPUTER MODEL; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIET; FLUORINATION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HYDROGEN BOND; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DOCKING; NONHUMAN; RAINBOW TROUT; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION;

ANIMALIA; ONCORHYNCHUS MYKISS; SALMONIDAE;

EID: 79952091852     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq379     Document Type: Article

References (55)

1. Abagyan, R., Totrov, M., and Kuznetsov, D. (1994). ICM-a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem. 15, 488-506.
2. Abdellatif, A. G., Preat, V., Taper, H. S., and Roberfroid, M. (1991). The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator. Toxicol. Appl. Pharmacol. 1ll, 530-537.
3. Benninghoff, A. D., and Williams, D. E. (2008). Identification of a transcriptional fingerprint of estrogen exposure in rainbow trout liver. Toxicol. Sci. 101, 65-80.
4. Bisson, W. H., Koch, D. C., O'Donnell, E. F., Khalil, S. M., Kerkvliet, N. I., Tanguay, R. L., Abagyan, R., and Kolluri, S. K. (2009). Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands. J. Med. Chem. 52, 5635-5641.
5. Blair, R. M., Fang, H., Branham, W. S., Hass, B. S., Dial, S. L., Moland, C. L., Tong, W., Shi, L., Perkins, R., and Sheehan, D. M. (2000). The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol. Sci. 54, 138-153.
6. Bosgra, S., Mermes, W., and Seinen, W. (2005). Proceedings in uncovering the mechanism behind peroxisome proliferator-induced hepatocarcinogenesis. Toxicology 206, 309-323.
7. Brzozowski, A. M., Pike, A. C, Dauter, Z., Hubbard, R. E., Bonn, T., Engstrom, O., Ohman, L., Greene, G. L., Gustafsson, J. A., and Carlquist, M. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758.
8. Calafat, A. M., Wong, L. Y., Kuklenyik, Z., Reidy, J. A., and Needham, L. L. (2007). Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ. Health Perspect. 115. 1596-1602.
9. Cardozo, T., Totrov, M., and Abagyan, R. (1995). Homology modeling by the ICM method. Proteins 23, 403-414.
10. Cavalieri, E., Frenkel, K., Liehr, J. G., Rogan, E., and Roy, D. (2000). Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J. Natl. Cancer Inst. Monogr. 27, 75-93.
11. De Maria, N., Manno, M., and Villa, E. (2002). Sex hormones and liver cancer. Mol. Cell. Endocrinol. 193, 59-63.
12. liassen, A. H., and Hankinson, S. E. (2008). Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv. Exp. Med. Biol. 630, 148-165.
13. Emmett, E. A., Shofer, F. S., Zhang, H., Freeman, D., Desai, C, and Shaw, L. M. (2006). Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J. Occup. Environ. Med. 48, 759-770.
14. Flouriot, G., Griffin, C, Kenealy, M., Sonntag-Buck, V., and Gannon, F. (1998). Differentially expressed messenger RNA isoforms of the human estrogen receptor-alpha gene are generated by alternative splicing and promoter usage. Mol. Endocrinol. 12, 1939-1954.
15. Fromme, H., Tittlemier, S. A., Volkel, W., Wilhelm, M., and Twardella, D. (2009). Perfluorrnated compounds-exposure assessment for the general population in Western countries. Int. J. Hyg. Environ. Health 212, 239-270.
16. Guyton, K. Z., Chiu, W. A., Bateson, T. F., Jinot, J., Scott, C. S., Brown, R. C, and Caldwell, J. C. (2009). A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants. Environ. Health Perspect. 117, 1664-1672.
17. Hanhijarvi, H., Ylinen, M., Haaranen, T., and Nevalainen, T. (1988). In A Proposed Species Difference in the Renal Excretion of Perfluorooctanoic Acid in the Beagle Dog and Rat (A. C. Beynen and H. A. Solleveld, Eds.). pp. 409-412. Martinus Nijhoff Publishers, Dordrecht, The Netherlands.
18. Ho, S. M. (2003). Estrogen, progesterone and epithelial ovarian cancer. Reprod. Biol. Endocrinol. 1, 73.
19. Holden, P. R., and Tugwood, J. D. (1999). Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences. J. Mol. Endocrinol. 22, 1-8.
20. Houde, M., Martin, J. W., Letcher, R. J., Solomon, K. R., and Muir, D. C. (2006). Biological monitoring of polyfluoroalkyl substances: a review. Environ. Sci. Technol. 40, 3463-3473.
21. Ishibashi, H., Ishida, H., Matsuoka, M., Tominaga, N., and Arizono, K. (2007). Estrogenic effects of fluorotelomer alcohols for human estrogen receptor isoforms alpha and beta in vitro. Biol. Pharm. Bull. 30. 1358-1359.
22. Ishibashi, H., Yamauchi, R., Matsuoka, M., Kim, J. W., Hirano, M.: Yamaguchi, A., Tomrnaga, N., and Arizono, K. (2008). Fluorotelomer alcohols induce hepatic vitellogenin through activation of the estrogen receptor in male medaka (Oryzias ¡atipes). Chemosphere 71, 1853-1859.
23. Ito, Y., Yamanoshita, O., Asaeda, N., Tagawa, Y., Lee, C. H., Aoyama, T.. Ichihara, G., Furuhashi, K., Kamijima, M., Gonzalez, F. J., et al. (2007). Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor alpha-independent pathway. J. Occup. Health 49, 172-182.
24. Kannan, K., Corsolini, S., Falandysz, J., Fillmann, G., Kumar, K. S., Loganathan, B. G., Mohd, M. A., Olivero, J., Van Wouwe, N., Yang, J. H., et al. (2004). Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ. Sci. Technol. 38, 4489-4495.
25. Kannan, K., Corsolini, S., Falandysz, J., Oehme, G., Focardi, S., an Giesy, J. P. (2002). Perfluorooctanesulfonate and related fluorinated hydrocarbons in marine mammals, fishes, and birds from coasts of the Baltic and the Mediterranean Seas. Environ. Sci. Technol. 36, 3210-3216.
26. Kennedy, G. L., Jr., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C, Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., and Farrar, D. G. (2004). The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 34, 351-384.
27. Kolluri, S. K., Bruey-Sedano, N., Cao, X., Lin, B., Lin, F., Han, Y. H., Dawson, M. I., and Zhang, X. K. (2003). Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells. Mol. Cell. Biol. 23, 8651-8667.
28. Kudo, N., and Kawashima, Y. (2003). Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J. Toxicol. Sci. 28, 49-57.
29. Lai, D. Y. (2004). Rodent carcinogenicity of peroxisome proliferators and issues on human relevance. J. Environ. Sci. Health C 22, 37-55.
30. Liu, C, Deng, J., Yu, L., Ramesh, M., and Zhou, B. (2010). Endocrine disruption and reproductive impairment in zebrafish by exposure to 8:2 fluorotelomer alcohol. Aquat. Toxicol. 96, 70-76.
31. Liu, C, Du, Y., and Zhou, B. (2007). Evaluation of estrogenic activities and mechanism of action of perfluorrnated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes. Aquat. Toxicol. 85, 267-277.
32. Liu, C, Yu, L., Deng, J., Lam, P. K., Wu, R. S., and Zhou, B. (2009). Waterborne exposure to fluorotelomer alcohol 6:2 FTOH alters plasma sex hormone and gene transcription in the hypothalamic-pituitary-gonadal (HPG) axis of zebrafish. Aquat. Toxicol. 93, 131-137.
33. Maras, M., Vanparys, C, Muylle, F., Robbens, J., Berger, U., Barber, J. L., Blust, R., and De Coen, W. (2006). Estrogen-like properties of fluorotelomer alcohols as revealed by mcf-7 breast cancer cell proliferation. Environ. Health Perspect. 114, 100-105.
34. Marchand-Geneste, N., Cazaunau, M., Carpy, A. J., Laguerre, M., Porcher, J. M., and Devillers, J. (2006). Homology model of the rainbow trout estrogen receptor (rtERalpha) and docking of endocrine disrupting chemicals (EDCs). SAR QSAR Environ. Res. 17, 93-105.
35. Martin, J. W., Mabury, S. A., and O'Brien, P. J. (2005). Metabolic products and pathways of fluorotelomer alcohols in isolated rat hepatocytes. Chem. Biol. Interact. 155, 165-180.
36. Martin, J. W., Mabury, S. A., Solomon, K. R., and Muir, D. C. (2003). Dietary accumulation of perfluorrnated acids in juvenile rainbow trout (Oncorhynchus mykiss). Environ. Toxicol. Chem. 22, 189-195.
37. Matthews, J., Celius, T., Halgren, R., and Zacharewski, T. (2000). Differential estrogen receptor binding of estrogenic substances: a species comparison. J. Steroid Biochem. Mol. Biol. 74, 223-234.
38. Mitchell, A. M., Lhuguenot, J. C, Bridges, J. W., and Elcombe, C. R. (1985). Identification of the proximate peroxisome proliferator(s) derived from di(2-ethylhexyl) phthalate. Toxicol. Appl. Pharmacol. 80, 23-32.
39. Nabb, D. L., Szostek, B., Himmelstein, M. W., Mawn, M. P., Gargas, M. L., Sweeney, L. M., Stadler, J. C, Buck, R. C, and Fasano, W. J. (2007). In vitro metabolism of 8-2 fluorotelomer alcohol: interspecies comparisons and metabolic pathway refinement. Toxicol. Sci. 100, 333-344.
40. Nagler, J. J., Cavileer, T., Sullivan, J., Cyr, D. G., and Rexroad, C, III. (2007). The complete nuclear estrogen receptor family in the rainbow trout: discovery of the novel ERalpha2 and both ERbeta isoforms. Gene 392, 164-173.
41. 1 hepatocarcinogenesis in rainbow trout by 17β-estradiol. Aquat. Toxicol. 15, 289-302.
42. Olsen, C. M., Meussen-Elholm, E. T., Hongslo, J. K., Stenersen, J., and Tollefsen, K. E. (2005). Estrogenic effects of environmental chemicals: an interspecies comparison. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 141, 267-274.
43. Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., and Zobel, L. R. (2007). Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 115, 1298-1305.
44. Orner, G. A., Mathews, C, Hendricks, J. D., Carpenter, H. M., Bailey, G. S., and Williams, D. E. (1995). Dehydroepiandrosterone is a complete hepatocarcinogen and potent tumor promoter in the absence of peroxisome proliferation in rainbow trout. Carcinogenesis 16, 2893-2898.
45. Palmer, C. N., Hsu, M. H., Griffin, K. J., Raucy, J. L., and Johnson, E. F. (1998). Peroxisome proliferator activated receptor-alpha expression in human liver. Mol. Pharmacol. 53, 14-22.
46. Persson, I. (2000). Estrogens in the causation of breast, endometrial and ovarian cancers-evidence and hypotheses from epidemiological findings. J. Steroid Biochem. Mol. Biol. 74. 357-364.
47. Shilling, A. D., and Williams, D. E. (2000). Determining relative estrogenicity by quantifying vitellogenin induction in rainbow trout liver slices. Toxicol. Appl. Pharmacol. 164, 330-335.
48. Sivanesan, D., Rajnarayanan, R. V., Doherty, J., and Pattabiraman, N. (2005). In-silico screening using flexible ligand binding pockets: a molecular dynamics-based approach. J. Comput. Aided Mol. Des. 19, 213-228.
49. Tilton, S. C, Orner, G. A., Benninghoff, A. D., Carpenter, H. M., Hendricks, J. D., Pereira, C.B., and Williams, D. E. (2008). Genomic profiling reveals an alternate mechanism for hepatic tumor promotion by perfluorooctanoic acid in rainbow trout. Environ. Health Perspect. 116, 1047-1055.
50. Totrov, M., and Abagyan, R. (1997). Flexible protein-ligand docking by global energy optimization in internal coordinates. Proteins Suppl 1, 215-220.
51. Totrov, M., and Abagyan, R. (2001). In Protein-Ligand Docking as an Energy Optimization Problem (R. B. Raffa, Ed.), pp. 603-624. John Wiley & Sons, New York, NY.
52. Villa, E. (2008). Role of estrogen in liver cancer. Womens Health (Lond. Engl.) 4, 41-50.
53. Wei, Y., Dai, J., Liu, M., Wang, J., Xu, M., Zha, J., and Wang, Z. (2007). Estrogen-like properties of perfluorooctanoic acid as revealed by expressing hepatic estrogen-responsive genes in rare minnows (Gobiocypris rarus). Environ. Toxicol. Chem. 26, 2440-2447.
54. Yager, J. D., Zurlo, J., and Ni, N. (1991). Sex hormones and tumor promotion in liver. Proc. Soc. Exp. Biol. Med. 198, 667-674.
55. Yeh, S. H., and Chen, P. J. (2010). Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology 78(Suppl. 1), 172-179.